Literature DB >> 16025011

The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay.

Raffaele Pezzilli, Antonio M Morselli-Labate, Federica Palladoro, Davide Campana, Lydia Piscitelli, Paola Tomassetti, Roberto Corinaldesi.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16025011     DOI: 10.1097/01.mpa.0000167002.96641.70

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  5 in total

Review 1.  Human pancreatic digestive enzymes.

Authors:  David C Whitcomb; Mark E Lowe
Journal:  Dig Dis Sci       Date:  2007-01-05       Impact factor: 3.199

2.  Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.

Authors:  Raffaele Pezzilli; Alessandra Barassi; Antonio M Morselli-Labate; Lorenzo Fantini; Paola Tomassetti; Davide Campana; Riccardo Casadei; Sergio Finazzi; Gianvico Melzi d'Eril; Roberto Corinaldesi
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

3.  Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis.

Authors:  Rohini R Vanga; Aylin Tansel; Saad Sidiq; Hashem B El-Serag; Mohamed O Othman
Journal:  Clin Gastroenterol Hepatol       Date:  2018-01-31       Impact factor: 11.382

Review 4.  Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas.

Authors:  Raffaele Pezzilli; Angelo Andriulli; Claudio Bassi; Gianpaolo Balzano; Maurizio Cantore; Gianfranco Delle Fave; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 5.  Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer.

Authors:  Raffaele Pezzilli; Riccardo Caccialanza; Gabriele Capurso; Oronzo Brunetti; Michele Milella; Massimo Falconi
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.